Skip to content

9EPANOSTIKA(Tm) Anti-Hav Igm

by Organon Teknika Corp.

PMA P830017

Active United States

PMA

Valid until

No expiry

PMA approval is not time-limited

FDA recalls

None found

in data synced 6 Oct 2026

Documents

PMA P830017↗

FDA record

Trust

Unverified

Registry data, not yet checked by deviCERTS. Source FDA PMA, synced 6 Oct 2026. What this means

Regulatory status

as of registry sync 6 Oct 2026

RegionAuthorizationNumberDateStatus
United StatesFDA PMAAPPR Approved 1 supplement NumberP830017 Date21 Mar 1990ApprovedStatusActive

Recalls

0 recalls · FDA

No FDA recalls found in the data synced 6 Oct 2026.

Coverage

1 jurisdiction

United States of America
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not covered

United States — FDA PMA Active

Specification

PMA

Generic Name
Hepatitis a test (antibody and igm antibody)
PMA Number
FDA Product Code
LOL
Device Class
Class II
Regulation
21 CFR Part 866.3310
Advisory Committee
Microbiology
FDA Decision
APPR Approved
PMA Supplement
S001 (Normal 180 Day Track)

Overview

AI-generated summary, 18 Sep 2026

Written by a language model from registry data. Not verified by deviCERTS or the manufacturer. The registry data above is the record.

The 9Epanostika Anti-HAV IgM is an in vitro diagnostic device classified as a Hepatitis A Test (Antibody and IgM Antibody). It is designed to detect IgM antibodies to Hepatitis A virus (HAV) in human serum or plasma, aiding in the diagnosis of acute Hepatitis A infection.

This device is intended for use in clinical microbiology laboratories. Supplied as a single-use reagent kit, it requires no sterilisation beyond its original packaging. The test is regulated under FDA Premarket Approval (PMA) with PMA number P830017 and falls under regulation number 866.3310. Storage and handling follow standard in vitro diagnostic procedures as specified in the accompanying instructions.

Other devices from Organon Teknika Corp.

See all devices from Organon Teknika Corp. →

Questions

AI-generated answers, 18 Sep 2026

Written by a language model from registry data. Not verified by deviCERTS or the manufacturer. The registry data above is the record.

  • What clinical purpose does the 9Epanostika Anti-HAV IgM test serve in diagnosing Hepatitis A infections?

    The 9Epanostika Anti-HAV IgM test detects IgM antibodies to the Hepatitis A virus (HAV) in human serum or plasma, helping clinicians identify acute Hepatitis A infections. IgM antibodies appear early during infection, making this test useful for confirming recent or active cases.

  • Is this test kit designed for single-use, or can it be reused after opening?

    The 9Epanostika Anti-HAV IgM is supplied as a single-use reagent kit. It does not require sterilization beyond its original packaging, and the manufacturer does not recommend reuse after opening to maintain accuracy and prevent contamination.

  • How is this device regulated, and what does that mean for laboratories using it?

    The 9Epanostika Anti-HAV IgM is regulated under the FDA’s Premarket Approval (PMA) pathway with PMA number P830017 and falls under regulation 866.3310. This means it has undergone rigorous review by the FDA to ensure safety, effectiveness, and proper labeling before clinical use. Laboratories must follow the included instructions for storage, handling, and testing to comply with regulatory requirements.

  • What storage and handling precautions should be taken with this test kit?

    While specific storage details are outlined in the accompanying instructions, standard in vitro diagnostic procedures apply. The kit should be stored as directed to preserve its integrity, typically in a clean, dry environment away from extreme temperatures or direct light. Always refer to the manufacturer’s guidelines for exact conditions.